Literature DB >> 30575435

Moving galectin-3 closer to the goal line.

Jonathan A Kirk1, Rudolf A de Boer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30575435      PMCID： PMC6415817          DOI： 10.1152/ajpheart.00761.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  10 in total

Review 1.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  Circulation       Date:  2017-04-28       Impact factor: 29.690

2.  Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β2-adrenoceptor overexpression.

Authors:  My-Nhan Nguyen; Yidan Su; Helen Kiriazis; Yan Yang; Xiao-Ming Gao; Julie R McMullen; Anthony M Dart; Xiao-Jun Du
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-09       Impact factor: 4.733

3.  Galectin-3 in the pathogenesis of heart failure: a causative mediator or simply a biomarker?

Authors:  Jonathan A Kirk; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-02       Impact factor: 4.733

4.  Galectin-3, Cardiac Function, and Fibrosis.

Authors:  Wouter C Meijers; Natalia López-Andrés; Rudolf A de Boer
Journal:  Am J Pathol       Date:  2016-07-20       Impact factor: 4.307

5.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.

Authors:  Shimako Yamamoto; Guiping Yang; Daniela Zablocki; Jing Liu; Chull Hong; Song-Jung Kim; Sandra Soler; Mari Odashima; Jill Thaisz; Ghassan Yehia; Carlos A Molina; Atsuko Yatani; Dorothy E Vatner; Stephen F Vatner; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

6.  Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.

Authors:  Olga Frunza; Ilaria Russo; Amit Saxena; Arti V Shinde; Claudio Humeres; Waqas Hanif; Vikrant Rai; Ya Su; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2016-03-03       Impact factor: 4.307

7.  Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.

Authors:  My-Nhan Nguyen; Mark Ziemann; Helen Kiriazis; Yidan Su; Zara Thomas; Qun Lu; Daniel G Donner; Wei-Bo Zhao; Haloom Rafehi; Junichi Sadoshima; Julie R McMullen; Assam El-Osta; Xiao-Jun Du
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-02       Impact factor: 4.733

8.  Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.

Authors:  John Stegmayr; Adriana Lepur; Barbro Kahl-Knutson; Matilde Aguilar-Moncayo; Anatole A Klyosov; Robert A Field; Stina Oredsson; Ulf J Nilsson; Hakon Leffler
Journal:  J Biol Chem       Date:  2016-04-26       Impact factor: 5.157

Review 9.  Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.

Authors:  Navin Suthahar; Wouter C Meijers; Herman H W Silljé; Jennifer E Ho; Fu-Tong Liu; Rudolf A de Boer
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 10.  Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions.

Authors:  Yi-Chen Chan; Hsien-Ya Lin; Zhijay Tu; Yen-Hsi Kuo; Shang-Te Danny Hsu; Chun-Hung Lin
Journal:  Int J Mol Sci       Date:  2018-01-29       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.